研报掘金丨东吴证券:首予天士力“买入”评级,华润入主强强联合

格隆汇资讯
23 Jun

东吴证券研报指出,天士力为中药现代化领军企业,华润入主,强强联合,优势互补。华润三九和天士力有望实现中药产业链的补链强链延链,发挥研发协同价值,提升创新发展能力,形成品牌势能。一方面,天士力有望发挥中药创新研发、智能化生产的优势;另一方面,华润三九强大的品牌打造能力和渠道优势有望为天士力赋能,推动天士力产品院外市场的开拓,后续融合发展值得期待。公司基本盘稳中向好,研发能力靠前,华润三九入主后有望...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10